HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Glossophobia

Also Known As:

Fear of public speaking; Fear of speaking in public; Phobia, public speaking

Networked: 6 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Mental Disorders: 24177
- Anxiety Disorders: 7356
  - Phobic Disorders: 1089
    - Social Phobia: 1324
      - Glossophobia: 6

Related Diseases

1.	Social Phobia

Experts

1.	Elsey, James W B: 1 article (01/2020)
2.	Filmer, Anna I: 1 article (01/2020)
3.	Galvin, Harriet R: 1 article (01/2020)
4.	Kindt, Merel: 1 article (01/2020)
5.	Kurath, Jennifer D: 1 article (01/2020)
6.	Thomander, Linnea S: 1 article (01/2020)
7.	Vossoughi, Linos: 1 article (01/2020)
8.	Zavodnik, Melissa: 1 article (01/2020)
9.	Bystritksy, Alexander: 1 article (11/2019)
10.	Craske, Michelle G: 1 article (11/2019)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Glossophobia:

1.	Propranolol (Inderal)FDA LinkGeneric 01/01/2020 - "Reconsolidation-based treatment for fear of public speaking: a systematic pilot study using propranolol." 09/01/1991 - "Propranolol and other beta-blockers may also be useful in the prevention of performance anxiety such as the fear of speaking in public or specific social phobias when limited in number in the same patients. "
2.	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/01/2010 - "This fear-enhancing effect of escitalopram agrees with previously reported results with less selective serotonin reuptake inhibitors and the receptor antagonist ritanserin, indicating that serotonin inhibits the fear of speaking in public."
3.	RitanserinIBA 05/01/2010 - "This fear-enhancing effect of escitalopram agrees with previously reported results with less selective serotonin reuptake inhibitors and the receptor antagonist ritanserin, indicating that serotonin inhibits the fear of speaking in public."
4.	Serotonin (5 Hydroxytryptamine)IBA 05/01/2010 - "This fear-enhancing effect of escitalopram agrees with previously reported results with less selective serotonin reuptake inhibitors and the receptor antagonist ritanserin, indicating that serotonin inhibits the fear of speaking in public."
5.	Scopolamine (Hyoscine)FDA Link 11/01/2019 - "A total of 60 participants (35 female, 22 male, 1 transgender, 2 undeclared) with social anxiety disorder and fear of public speaking were randomized to placebo, 0.5 mg scopolamine, or 0.6 mg scopolamine. "
6.	Escitalopram FDA Link 05/01/2010 - "This fear-enhancing effect of escitalopram agrees with previously reported results with less selective serotonin reuptake inhibitors and the receptor antagonist ritanserin, indicating that serotonin inhibits the fear of speaking in public."

Therapies and Procedures

1.	Therapeutics 06/01/2013 - "Studies comparing VRET to pharmacological therapy are lacking, and there are few randomized controlled trials that compare VRET to CBT, especially on fear of public speaking treatment."
2.	Smart Glasses 01/01/2001 - "The purpose was to assess the extent to which social anxiety, specifically fear of public speaking, was induced by the virtual audience and the extent of influence of degree of immersion (head mounted display or desktop monitor. "